SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001072613-05-000041
Filing Date
2005-01-07
Accepted
2005-01-07 20:42:33
Documents
1
Period of Report
2005-01-05

Document Format Files

Seq Description Document Type Size
1 pro_13191ex.html 4  
1 pro_13191ex.xml 4 14425
  Complete submission text file 0001072613-05-000041.txt   16294
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661
SIC: 2834 Pharmaceutical Preparations

Mailing Address 38 JERMYN STREET LONDON X0 SW1Y 6DN
Business Address 38 JERMYN STREET LONDON X0 SW1Y 6DN 44 20 7534 1508
Abingworth Management LTD (Reporting) CIK: 0001291892 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50743 | Film No.: 05519475